文献
J-GLOBAL ID:202002243250248128
整理番号:20A0069924
Duchenne型筋ジストロフィーに対するデフラザac対プレドニゾン治療:最近の多施設臨床試験における疾患進行率のメタ分析【JST・京大機械翻訳】
Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta-analysis of disease progression rates in recent multicenter clinical trials
著者 (13件):
McDonald Craig M.
(Physical Medicine and Rehabilitation Pediatrics, University of California Davis Health System, Sacramento, California)
,
Sajeev Gautam
(Analysis Group, Inc, Boston, Massachusetts)
,
Yao Zhiwen
(Analysis Group, Inc, Boston, Massachusetts)
,
McDonnell Erin
(Analysis Group, Inc, Boston, Massachusetts)
,
Elfring Gary
(PTC Therapeutics, Inc, South Plainfield, New Jersey)
,
Souza Marcio
(PTC Therapeutics, Inc, South Plainfield, New Jersey)
,
Peltz Stuart W.
(PTC Therapeutics, Inc, South Plainfield, New Jersey)
,
Darras Basil T.
(Department of Neurology, Boston Children’s Hospital, Boston, Massachusetts)
,
Shieh Perry B.
(Neurology, University of California at Los Angeles, Los Angeles, California)
,
Cox David A.
(Eli Lilly and Company, Indianapolis, Indiana)
,
Landry John
(Eli Lilly and Company, Toronto, Ontario, Canada)
,
Signorovitch James
(Analysis Group, Inc, Boston, Massachusetts)
,
for the ACT DMD Study Group and the Tadalafil DMD Study Group
資料名:
Muscle & Nerve
(Muscle & Nerve)
巻:
61
号:
1
ページ:
26-35
発行年:
2020年
JST資料番号:
A1518A
ISSN:
0148-639X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)